, Volume 14, Issue 2, pp 124-129
Date: 08 Mar 2012

The J-Point Phenomenon in Aggressive Therapy of Hypertension: New Insights

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


In the era of aggressive control of cardiovascular risk factors such as hypertension, the mantra of “lower is better” has taken a strong foothold. Although there is clear epidemiologic evidence that lower blood pressure improves specific organ-related outcomes, this rule does not apply to all patients and definitely not all target organs. The concept of J-curve or adverse outcomes at lower blood pressure has been proposed for more than three decades but has recently come under increasing scrutiny. Specifically, a relationship between adverse cardiovascular outcomes and low diastolic blood pressure has been observed in multiple clinical trials. In this article we review the advances in understanding of the J-curve phenomenon and include a discussion on specific populations that might be at higher risk due to the J-curve relationship.